Radiochemical studies relevant to 86Y production via 86Sr(p,n)86Y for PET imaging

Applied Radiation and Isotopes

Volumn 67, Issue 1, 2009, Pages 7-10

  Sadeghi, M ^a,b   Aboudzadeh, M ^a   Zali, A ^b   Mirzaii, M ^a   Bolourinovin, F ^a,b  

^a AGRICULTURAL MEDICAL AND INDUSTRIAL RESEARCH SCHOOL   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Cyclotron; Production; Separation; Strontium carbonate; Yttrium 86

Indexed keywords

ALKALINE EARTH METALS; COPPER; ION EXCHANGE; ISOMERS; SEDIMENTATION; STRONTIUM; STRONTIUM COMPOUNDS; YTTRIUM;

NATURAL TARGETS; PET IMAGING; PRODUCTION TECHNIQUES; PRODUCTION YIELDS; STRONTIUM CARBONATE; STRONTIUM CARBONATES;

YTTRIUM ALLOYS;

COPPER ION; GERMANIUM; RADIOISOTOPE; STRONTIUM; STRONTIUM 86; STRONTIUM CARBONATE; UNCLASSIFIED DRUG; YTTRIUM 86;

ARTICLE; ATOMIC EMISSION SPECTROMETRY; CYCLOTRON; GAMMA SPECTROMETRY; IMAGING SYSTEM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOCHEMISTRY; SEDIMENTATION; TEMPERATURE;

CARBONATES; CHROMATOGRAPHY, ION EXCHANGE; COPPER; POSITRON-EMISSION TOMOGRAPHY; PROTONS; RADIOCHEMISTRY; RADIOPHARMACEUTICALS; STRONTIUM; YTTRIUM RADIOISOTOPES;

EID: 56649124641     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2008.08.017     Document Type: Article

References (28)

1. 88Y from a SrCl2 target using chelating resin Chelex 100. Radioanal. Nucl. Chem. 270 3 (2006) 641-643
2. 86Sr targets. Appl. Radiat. Isot. 66 (2008) 9-13
3. Blann, M., 1991. ALICE-91 Statistical Model Code System with Fission Competition. RSIC Code Package PSR (146).
4. 90Y-conjugates: clinical application with 90Y-DOTATOC. J. Nucl. Med. 47 1 (2006) 105-112
5. Finn R.D., McDevitt M., Ma D., Jurcic J., Scheinderg D., Larson S., Shoner S., Link J., Krohn K., and Schlyer D. Low energy cyclotron production and separation of yttrium-86 for evaluation of monoclonal antibody pharmacokinetics and dosimetry. AIP Conf. Proc. 475 (1999) 991-993
6. Friedlander G., Kennedy J.W., Macias E.S., and Miller J.M. Nuclear and Radiochemistry. third ed (1981), Wiley, New York p. 291
7. 111In labeled Herceptin™. Nucl. Med. Biol. 29 5 (2002) 599-606
8. 111In-pentetreotide in patients with advanced neuroendocrine tumours. Eur. J. Nucl. Med. 31 10 (2004) 1386-1392
9. Herzog H., Rosch F., Stocklin G., Lueders C., Qaim S.M., and Feinendegen L.E. Measurement of pharmacokinetic of yttrium-86 radiopharmaceuticals with PET and radiation dose calculation of analogous Yttrium-90 radiotherapeutics. J. Nucl. Med. 34 12 (1993) 2222-2226
10. 86Y-DOTA0-D-Phe1-Tyr3-octreotide (SMT487)-a phase clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion. Eur. J. Nucl. Med. 30 4 (2003) 510-518
11. 88Y at a small-sized cyclotron. Radiochim. Acta 90 (2002) 845-849
12. Koning, A.J., Hilaire, S., Duijvestijn, M.C., 2005. TALYS: comprehensive nuclear reaction modeling. In: Proceedings of the International Conference on Nuclear Data for Science and Technology-ND2004, AIP, vol. 769, p. 1154.
13. + in 2D Mode. Cancer Biother. Radiopharm. 19 4 (2004) 482-490
14. Levkovskij, V.N., 1991. Activation cross section nuclides of average masses (a=40-100) by protons and alpha-particles with average energies (E=10-50 MeV), Levkovskij, ActCs. By Protons and Alphas, Moscow.
15. 111In radiolabels. J. Nucl. Med. 42 8 (2001) 1281-1287
16. Marczenko Z. Spectrophotometric Determination of Elements. fourth ed (1976), Wiley, New York p. 601
17. 11), a cyclized peptide analogue of α-MSH. J. Med. Chem. 48 8 (2005) 2985-2992
18. 86Y. Appl. Radiat. Isot. 64 (2006) 1521-1527
19. 90Y dosimetry in an ovarian carcinoma model: correlative microPET and MRI. J. Nucl. Med. 44 7 (2003) 1148-1155
20. 86Y purification using a three-column system. Nucl. Med. Biol. 31 2 (2004) 297-301
21. Reisch G., Rosch F., and Machulla H.J. Electrochemical separation and purification of yttrium-86. Radiochim. Acta 90 (2002) 225-228
22. 3He,xn)-processes. Radiochim. Acta 61 (1993) 1-8
23. 86Y for nuclear medical application. Appl. Radiat. Isot. 44 4 (1993) 677-681
24. Rosch F., Herzog H., Plag C., Neumaier B., Braun U., Gartner H.W.M., and Stocklin G. Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomography. Eur. J. Nucl. Med. 23 8 (1996) 958-966
25. Walrand S., Jamar F., Mathieu I., Camps J., Lonneux M., Sibomana M., Labar D., Michel C., and Pauwels S. Quantitation in PET using isotopes emitting prompt single gammas: application to yttrium-86. Eur. J. Nucl. Med. 30 (2003) 354-361
26. Wei L., Miao Y., Gallazzi F., Quinn T.P., Welch M.J., Vavere A.L., and Lewis J.S. Gallium-68-labeled DOTA-rhenium-cyclized α-melanocyte-stimulating hormone analog for imaging of malignant melanoma. Nucl. Med. Biol. 34 (2007) 945-953
27. 86Y using a small biomedical cyclotron. Nucl. Med. Biol. 32 8 (2005) 891-897
28. Ziegler J.F., Biersack J.P., and Littmark U. The Code of SRIM-the Stopping and Range of Ions in Matter (2003), IBM-Research, New York, USA